Epstein Secrets

The AR (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases Spike. ABC World News Tonight (10/22, story 4, 3:00, Muir, 6.71M) r

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

d Bloomberg <https://www.bloomberg.corninews/articles/2020-10-22/yields-up-on-stimulus-hopes-asia-stocks-to-drift- markets-wrap?smd=premium> (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases Spike. ABC World News Tonight <https://playvideo.bulletinintelligence

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

The AP (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide similar coverage. FDA Officially Approves Remdesivir As Cases Spike. ABC World News TonightVi (10/22, story 4, 3:00, Muir, 6.71M) r

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug